English
Transgene Biotek Q3 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
2.81
0.04 (1.44%)
0.04 (1.44%)Volume2.21 K
Updated: Fri 16 Jan, 2026 | 09:30:17
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.19 | 0.16 | 21.21% | 0.18 | 9.28% |
| Depreciation/ Amortization | 0.02 | 0.02 | 0.00% | 0.02 | 0.43% |
| Total Revenue | 0.08 | 0.06 | 30.77% | 0.05 | 70.00% |
| Operating Income | -0.12 | -0.10 | 15.62% | -0.13 | -11.63% |
| Net Income | -0.09 | -0.07 | 21.25% | -0.12 | -25.27% |
| Selling/ General/ Admin Expenses Total | 0.08 | 0.08 | -0.49% | 0.08 | 6.40% |
| Other Operating Expenses Total | 0.09 | 0.05 | 63.79% | 0.08 | 15.02% |
| Net Income Before Taxes | -0.09 | -0.07 | 21.25% | -0.12 | -25.27% |
| Diluted Normalized EPS | -0.01 | -0.01 | 17.50% | -0.02 | -41.25% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.